🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Piper Sandler keeps e.l.f. Beauty stock Overweight, sees potential in international growth

EditorAhmed Abdulazez Abdulkadir
Published 30/10/2024, 12:00
ELF
-

On Wednesday, Piper Sandler reaffirmed its Overweight rating on shares of e.l.f. Beauty (NYSE: NYSE:ELF), with a consistent price target of $162.00. The firm's stance comes ahead of the company's anticipated fiscal second-quarter results next week.

The financial institution expressed confidence in the cosmetics company, encouraging investors to increase their holdings now and in the months to follow. According to the firm, e.l.f. Beauty's stock is perceived as having minimized risk at its present value. The firm's recent evaluations of the company's efforts in international expansion, product innovation, and margin considerations suggest a favorable outlook for the upcoming quarterly report.

Piper Sandler predicts that these factors could result in e.l.f. Beauty's stock remaining stable or experiencing positive movement. The firm anticipates that the company's performance, coupled with strategic management decisions and a potential share buy-back program, may contribute to an increase in both financial estimates and the stock's valuation multiplier after the fiscal second-quarter results are released.

Investors are watching closely as e.l.f. Beauty prepares to disclose its financial performance, which could potentially affirm Piper Sandler's optimistic projections for the stock. The market awaits to see if the company's strategic initiatives and management's execution will indeed lead to the positive outcomes forecasted by the analyst firm.

In other recent news, e.l.f. Beauty has been the subject of several adjustments by financial analysts. Stifel lowered its price target for the company from $161 to $131, citing a slowdown in sales momentum. In contrast, Piper Sandler maintained its Overweight rating, emphasizing the company's growth potential in digital and international markets despite a slowdown in sales growth. Baird also reduced its price target from $240 to $175 due to slowing U.S. demand, but maintained an Outperform rating.

Truist Securities lowered its price target to $130 but maintained a Buy recommendation, while DA Davidson reaffirmed a Buy rating, maintaining a price target of $223. Morgan Stanley (NYSE:MS) reduced its target from $184 to $139, maintaining an Equalweight rating due to concerns over U.S. scanner data.

These are recent developments following e.l.f. Beauty's financial performance, which includes a 50% increase in net sales and an 80 basis point growth in gross margin. The company also authorized a new $500 million share repurchase program and raised its full-year outlook, projecting net sales growth of 25-27% and adjusted EBITDA growth of 26-28%.

InvestingPro Insights

As e.l.f. Beauty (NYSE: ELF) approaches its fiscal second-quarter earnings report, InvestingPro data provides additional context to Piper Sandler's optimistic outlook. The company's revenue growth remains robust, with a 68.32% increase over the last twelve months, reaching $1.13 billion. This aligns with the InvestingPro Tip that analysts anticipate sales growth in the current year.

e.l.f. Beauty's impressive gross profit margin of 70.91% underscores its strong market position and efficient cost management, supporting the InvestingPro Tip highlighting the company's impressive gross profit margins. This financial strength may contribute to the positive sentiment expressed by Piper Sandler.

However, investors should note that ELF is trading at a high P/E ratio of 51.76, which the InvestingPro Tips flag as a high earnings multiple. This valuation metric suggests that the market has high growth expectations for the company, which aligns with Piper Sandler's Overweight rating but also implies that the stock may be sensitive to earnings performance.

For a more comprehensive analysis, InvestingPro offers 16 additional tips for e.l.f. Beauty, providing investors with a deeper understanding of the company's financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.